Gene signature of drug response in AD predicts drug repurpose in asthma
Asthma is common in patients initially diagnosed with atopic dermatitis (AD). Using gene signatures of drug responses in patients with AD is helping us to repurpose specific drugs for patients with severe asthma. In this MEDtalk, Professor Ian Adock elaborates this new approach, that can be applied across among more drugs and diseases.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
